Hansoh Pharmaceutical Group Company Limited (HNSPF)

HNSPF Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	30,389	13,202	11,951	11,269	14,430	28,704
Market Cap Growth	91.76%	10.47%	6.05%	-21.91%	-49.73%	49.13%
Enterprise Value	26,582	9,968	9,325	8,742	12,233	26,321
Last Close Price	5.00	2.13	1.83	-	-	-
PE Ratio	45.53	22.04	25.86	30.08	33.79	72.95
PS Ratio	16.51	7.86	8.39	8.28	9.23	21.56
PB Ratio	7.00	3.36	3.29	3.43	4.58	10.48
P/TBV Ratio	7.07	3.39	3.31	3.44	4.58	10.49
P/FCF Ratio	48.46	26.47	29.25	31.49	43.30	194.63
P/OCF Ratio	45.49	24.95	27.19	28.35	35.57	78.39
EV/Sales Ratio	14.30	5.93	6.54	6.43	7.82	19.77
EV/EBITDA Ratio	38.96	17.01	21.86	20.57	25.20	57.49
EV/EBIT Ratio	42.29	18.65	24.68	23.13	27.55	61.97
EV/FCF Ratio	42.39	19.99	22.83	24.43	36.71	178.47
Debt / Equity Ratio	0.00	0.00	0.17	0.19	0.19	0.01
Debt / EBITDA Ratio	0.02	0.03	1.41	1.48	1.24	0.03
Debt / FCF Ratio	0.03	0.03	1.49	1.77	1.81	0.10
Asset Turnover	0.40	0.38	0.32	0.33	0.41	0.43
Inventory Turnover	1.93	1.82	2.02	2.03	2.46	2.25
Quick Ratio	8.31	9.90	4.11	9.64	7.50	6.30
Current Ratio	8.56	10.18	4.21	9.86	7.67	6.43
Return on Equity (ROE)	16.21%	16.05%	13.53%	12.11%	14.31%	16.62%
Return on Assets (ROA)	8.35%	7.54%	5.31%	5.70%	7.35%	8.59%
Return on Capital (ROIC)	9.41%	8.28%	5.86%	6.41%	8.43%	11.17%
Return on Capital Employed (ROCE)	14.20%	13.50%	10.20%	9.50%	11.70%	15.30%
Earnings Yield	2.20%	4.54%	3.87%	3.32%	2.96%	1.37%
FCF Yield	2.06%	3.78%	3.42%	3.18%	2.31%	0.51%
Dividend Yield	-	2.03%	1.49%	-	-	-
Payout Ratio	38.87%	42.51%	19.90%	27.56%	14.04%	163.49%
Buyback Yield / Dilution	1.10%	1.16%	-1.52%	1.14%	-2.04%	-7.31%
Total Shareholder Return	1.10%	3.19%	-0.03%	1.14%	-2.04%	-7.31%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.